Sun Pharmaceutical Industries Ltd.

SUNPHARMA

INE044A01036

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 05:13:56 18/07/2024 pm IST			5-day change	1st Jan Change
1,594 ^INR	+0.95%		+0.79%	+26.58%

11/07	Sun Pharmaceutical Industries Limited Receives an Order Passed by Office of the Commissioner of Customs, (NS-III), Jawaharlal Nehru Custom House, Taluka- Uran, District-Raigad, Maharashtra	CI
05/07	Bain-backed Emcure Pharma's $234 million India IPO draws $11 billion in bids	RE

Sun Pharmaceutical Industries Limited Proposes Interim Dividend for the Fiscal Year 2021

January 29, 2021 at 02:26 pm IST

Sun Pharmaceutical Industries Limited announced that at its board meeting held on January 29, 2021, the board has proposes an interim dividend of INR 5.50 per share for the fiscal year 2021.

Latest news about Sun Pharmaceutical Industries Ltd.

Sun Pharmaceutical Industries Limited Receives an Order Passed by Office of the Commissioner of Customs, (NS-III), Jawaharlal Nehru Custom House, Taluka- Uran, District-Raigad, Maharashtra	11/07	CI
Bain-backed Emcure Pharma's $234 million India IPO draws $11 billion in bids	05/07	RE
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe	02/07	RE
India plans incentives for diabetes, obesity drug makers in 2026, government official says	28/06	RE
Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner, CGST and Central Excise, Mumbai	27/06	CI
Sun Pharma Completes Taro Pharmaceutical Industries Merger	25/06	MT
Sun Pharmaceutical Industries Limited acquired remaining 21.5% stake in Taro Pharmaceutical Industries Ltd. from Krensavage Asset Management, LLC and others for approximately	24/06	CI
Sun Pharmaceutical Industries Limited Announces Results from A Phase 1, Multiple Ascending-Dose Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Gl0034 (Utreglutide) in Obese Adults	22/06	CI
Japanese Stocks End Little Changed After Three-Day Winning Streak on Inflation and Yen Woes	21/06	MT
Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India	21/06	RE
Sun Pharma Signs Deal with Japan's Takeda to Commercialize Vonoprazan in India	21/06	MT
Sun Pharma Signs Non-Exclusive Patent Licensing Agreement with Takeda for Introducing Novel Gastrointestinal Drug, Voltapraz in India	21/06	CI
Gains in Metal, Realty Stocks Help Indian Equities End Higher	20/06	MT
Sun Pharmaceutical Industries Gets US FDA's Warning Letter for Dadra, India Facility	20/06	MT
INDIA STOCKS-Indian shares muted as financials, pharma stocks weigh	20/06	RE
INDIA STOCKS-Indian shares open marginally higher led by private banks	20/06	RE
Sun Pharmaceutical to Acquire 9.6% Stake in Genome Software Haystack Analytics	07/06	MT
Sun Pharmaceutical Industries Limited agreed to acquire 9.61% stake in HaystackAnalytics Pvt. Ltd. for INR 330 million.	06/06	CI
Sun Pharmaceutical Industries Limited Receives an Order Passed by Joint Commissioner of State Tax CT& GST -Territorial Range -Bhubaneswar	04/06	CI
Philogen, Inc. and Sun Pharmaceutical Industries Limited Announces Results of the Phase III PIVOTAL Trial of Nidlegy in Melanoma	31/05	CI
Indian drugmakers to see FY25 revenue boost in key US market, says India Ratings and Research	27/05	RE
Sun Pharma to Pursue M&A	25/05	CI
Taro Pharmaceutical's Shareholders Approve Merger With Sun Pharmaceutical	23/05	MT
Indian Equities Hit Intraday Record Highs on Thursday, Lifted by Easing Poll Worries, Strong Domestic Buying	23/05	MT
Sun Pharmaceutical Clocks Gains in Fiscal Q4 Consolidated Net Profit	23/05	MT

Chart Sun Pharmaceutical Industries Ltd.

Duration

Period

Chart Sun Pharmaceutical Industries Ltd.

More charts

Sun Pharmaceutical Industries Ltd. is one of the Indian leaders of pharmaceutical groups. Net sales break down by family of products as follows: - generic and OTC medicines (94%): for cardiologic, psychiatric, neurological, gastroenterological, diabetic and respiratory diseases treatment; - other (6%) : primarily active pharmaceutical ingredients. At the end of March 2021, the group had 44 production plants worldwide. Net sales are distributed geographically as follows: India (33%), the United States (31.3%), other (35.7%).

Sector

Pharmaceuticals

Calendar

01/08/2024 - Q1 2025 Earnings Release

Related indices

NIFTY 50 , NIFTY 100

More about the company

Income Statement Evolution

More financial data

Ratings for Sun Pharmaceutical Industries Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1,579 INR

Average target price

1,629 INR

Spread / Average Target

+3.16%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+26.58%	4.53TCr
OTSUKA HOLDINGS CO., LTD.	+38.49%	2.54TCr
SANDOZ GROUP AG	+27.53%	1.67TCr
CIPLA LIMITED	+20.89%	1.46TCr
ZYDUS LIFESCIENCES LIMITED	+72.03%	1.43TCr
THE MEDICINES COMPANY	-0.05%	678.76Cr
ONO PHARMACEUTICAL CO., LTD.	-10.35%	666.89Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+13.07%	561.96Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
KRKA, D. D.	+35.45%	502.2Cr

Generic Pharmaceuticals

Sun Pharmaceutical Industries Ltd.

Equities

SUNPHARMA

INE044A01036

Pharmaceuticals

Sun Pharmaceutical Industries Limited Proposes Interim Dividend for the Fiscal Year 2021

EPS Revisions